December 26, 2014 3:17 AM ET

Biotechnology

Company Overview of Sequus Pharmaceuticals, Inc.

Company Overview

Sequus Pharmaceuticals, Inc. manufactures, develops, and distributes pharmaceutical products to treat cancer and infectious diseases. The company develops and markets DOXIL®, an anticancer drug; and AMPHOTEC®, an antifungal drug in the United States. The company was formerly known as Liposome Technology, Inc. and changed its name to Sequus Pharmaceuticals, Inc. in June, 1995. The company was founded in 1981 and is based in Menlo Park, California. As of March 17, 1999, Sequus Pharmaceuticals, Inc. operates as a subsidiary of ALZA Corporation.

960 Hamilton Court

Menlo Park, CA 94025

United States

Founded in 1981

Phone:

650-323-9011

Fax:

650-323-9160

Key Executives for Sequus Pharmaceuticals, Inc.

Vice President of Clinical Development and Medical Director
Age: 65
Associate Director of Finance
Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
Vitis Biosciences Inc. United States
Fluoresentric, Inc. United States
Bioactive Regenerative Therapeutics, Inc. United States
Transfusion & Transplantation Technologies, Inc. United States
Cambrian Genomics Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Sequus Pharmaceuticals, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.